DOI
Neil Turner, declaration of interests of potential relevance to professional roles.
Commercial
Income from these is directed towards research and education through the University of Edinburgh.
- Otsuka (Advisory Board, Speaker) pre-2018
- Shire-Takeda (Advisory Board, Speaker) 2019-20
- Sanofi-Genzyme (Advisory Board, Speaker) 2019-current
- Purespring (Consultancy, from 2021)
- Calliditas 2023
Authorship
Where royalties or other payments are received.
- Editor, Oxford Textbook of Clinical Nephrology, OUP.
Other
- Trustee of Alport UK from 2019 (honorary role)
Updated June 2023
Comments are closed
Comments to this thread have been closed by the post author or by an administrator.